Ultimele actualizari :
19/11/2024
Infostab
Listele
Listele
Cercetări de compatibilitate
Tabel de compatibilitate Y-site
Bibliografie
Echipe de cercetare
valistab
poster
Conexiuni
sponsori
Autor
Mod de utilizare
Newsletter
Bibliografie 1606
tip :
ziar
Echipe de cercetare :
Bethesda - National Institutes of Health Clinical Center
Autor :
Yuan P, Grimes GJ, Shankman SE, Daniels CE, Goldspiel BR, Potti GK.
titlu :
Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
Référence :
Am J Health-Syst Pharm ; 58: 594-598. 2001
Nivelul dovezii :
stabilitatea fizică :
Stabilitate chimică :
alte metode :
Comentarii :
Produsi de degradare detectati, dar nu cuantificati
Listele
Doxorubicin hydrochloride
Etoposide phosphate
Vincristine sulfate
2-6°C
Doxorubicin hydrochloride
0,12 mg/ml
Etoposide phosphate
0,6 mg/ml
Vincristine sulfate
0,005 mg/ml
5
2-6°C
Doxorubicin hydrochloride
0,24 mg/ml
Etoposide phosphate
1,2 mg/ml
Vincristine sulfate
0,010 mg/ml
5
2-6°C
Doxorubicin hydrochloride
0,4 mg/ml
Etoposide phosphate
2 mg/ml
Vincristine sulfate
0,016 mg/ml
5
35°C-40°C
Doxorubicin hydrochloride
0,12 mg/ml
Etoposide phosphate
0,6 mg/ml
Vincristine sulfate
0,005 mg/ml
5
35°C-40°C
Doxorubicin hydrochloride
0,24 mg/ml
Etoposide phosphate
1,2 mg/ml
Vincristine sulfate
0,010 mg/ml
5
35°C-40°C
Doxorubicin hydrochloride
0,4 mg/ml
Etoposide phosphate
2 mg/ml
Vincristine sulfate
0,016 mg/ml
5
Mentions Légales
